iGMDRD571


Canonical SMILES: COC1=CC2=C(C=CN=C2C=C1OC)OC3=CC=C(C=C3)NC(=O)C4(CC4)C(=O)NC5=CC=C(C=C5)F

InChI: InChI=1S/C28H24FN3O5/c1-35-24-15-21-22(16-25(24)36-2)30-14-11-23(21)37-20-9-7-19(8-10-20)32-27(34)28(12-13-28)26(33)31-18-5-3-17(29)4-6-18/h3-11,14-16H,12-13H2,1-2H3,(H,31,33)(H,32,34)

InChI Key: ONIQOQHATWINJY-UHFFFAOYSA-N

Loading, please wait...
Standard Name
CHEMBL
Pubchem CID
DRUGBANK ID
Drug Status
Drug Type
Standard NameCabozantinib
Pubchem CID25102800
DRUGBANK IDDB08875
Drug StatusAlone
Drug TypeSmall Molecule



Drug Pathways:

Other, kinases

Drug-model tissue-cancer distribution: Bubble Plot

Drug-gene pathway enrichments

Drug-gene GO enrichments

Drug-Gene: Aster Plot


Loading, please wait...
Gene ID
Gene Name
Model Num.
55252 ASXL2 1
7158 TP53BP1 1
7307 U2AF1 2
6098 ROS1 5
Showing 1 to 4 of 17 rows rows per page

Gene in drug-gene network: Network Plot

RITARITAnavitoclaxnavitoclaxcytochalasin.Bcytochalasin.BVER 155008VER 155008NSC95397NSC95397ABT737ABT737Merck60Merck60SepantroniumSepantroniumNsc 632839Nsc 632839SMR000068650SMR000068650ChloropentafluorobenzeneChloropentafluorobenzeneTP53BP1TP53BP1PP-30PP-30BIX01294BIX01294triacsin Ctriacsin CDC-45-A2DC-45-A2Compound.1541ACompound.1541AFedratinibFedratinibavrainvillamideavrainvillamidepevonedistatpevonedistatAC55649AC55649PTPN11PTPN11Belinostat (PXD101)Belinostat (PXD101)ASXL2ASXL2cetuximabcetuximabPI3K pathway inhibitors (alone or in combination)PI3K pathway inhibitors (alone or in combination)quinoclaminequinoclamineEverolimusEverolimusisoevodiamineisoevodiamineparbendazoleparbendazoletosedostattosedostatoligomycin.Aoligomycin.AML214ML214triptolidetriptolidePI3K pathway inhibitorsPI3K pathway inhibitorsBRD7137BRD7137BYL719 (Alpelisib)BYL719 (Alpelisib)trastuzumab alonetrastuzumab alonePIK3CAPIK3CABMS-754807BMS-754807salermidesalermideNutlin-3aNutlin-3aMytomycin CMytomycin CY-39983Y-39983NSC141540NSC141540Liposomal DoxorubicinLiposomal DoxorubicinGemcitabineGemcitabineCis-PlatinCis-PlatinindisulamindisulamTP53TP53selumetinib in BRAF mutant tumorsselumetinib in BRAF mutant tumorskinetin ribosidekinetin ribosideCDK4/6 inhibitorsCDK4/6 inhibitorsMEK inhibitorsMEK inhibitorsBI-2536BI-2536ubistatin Bubistatin BPanitumumabPanitumumabPLX-4720PLX-4720DabrafenibDabrafenibVemurafenibVemurafenibBinimetinib (MEK162)Binimetinib (MEK162)RefametinibRefametinibTrametinibTrametinibNRASNRASVandetanibVandetanibQuiflaponQuiflaponmanumycin.Amanumycin.APDMPPDMPRET inhibitorsRET inhibitorsVX-680VX-680(-)-gallocatechin-3-O-gallate(-)-gallocatechin-3-O-gallateBRD4770BRD4770nutlin 3nutlin 3PemetrexedPemetrexedRETRETQuizartinib (AC220)Quizartinib (AC220)SorafenibSorafenibCyanoquinoline, 11Cyanoquinoline, 11SunitinibSunitinibgossypolgossypolpurmorphaminepurmorphaminePonatinibPonatinibteniposideteniposidebatimastatbatimastatLexibulinLexibulinMidostaurinMidostaurincurcumincurcuminFLT3FLT3PI-103PI-103PF-2341066PF-2341066PRL-3 Inhibitor IPRL-3 Inhibitor IBRD6368BRD6368ABT-751ABT-751XL-880XL-880penfluridolpenfluridolTW-37TW-37ROS1ROS1BIRB-796BIRB-796PD0325901PD0325901MPS1-IN-1MPS1-IN-1WZ3105WZ3105CH5424802CH5424802GW2580GW2580WHI-P97WHI-P97QL-XII-61QL-XII-61MACF1MACF1BRD63610BRD63610TGX-115TGX-115SirolimusSirolimusTET2TET2GDC-0449GDC-0449tipifarnib-P2tipifarnib-P2CHEMBL585951CHEMBL585951tamatinibtamatinibVX-702VX-702NilotinibNilotinibBryostatin.1Bryostatin.1PF-3758309PF-3758309AS601245AS601245COX2COX2FK 866FK 866SB225002SB225002LY 2183240LY 2183240GMX1778GMX1778piperlonguminepiperlonguminezebularinezebularinePAC-1PAC-1CHM-1CHM-1SOS1SOS1BMS-536924BMS-536924bistramide Abistramide APARP inhibitorsPARP inhibitorsCD437CD437MAGI1MAGI1MET inhibitorsMET inhibitorsneopeltolideneopeltolideEGFR inhibitor 1st genEGFR inhibitor 1st genCHIR-99021CHIR-99021lapatinib in HER2-amplifiedlapatinib in HER2-amplifiedCapmatinibCapmatinibRNMTRNMTFLT3 inhibitorsFLT3 inhibitorsU2AF1U2AF1Tyrosine kinase inhibitorTyrosine kinase inhibitorMST-312MST-312DasatnibDasatnibAM-580AM-580Imatinib MesylateImatinib MesylateBosutinibBosutinibABL1ABL1XL-184XL-184

Models in Cabozantinib

Loading, please wait...
Model
Level
Reference ID
Tissue
Cancer
Drug
Clinical Response
Source
No matching records found

​​​​